Title
Category
Credits
Event date
Cost
Skilled Nursing Facilities Series: Dementia
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This on-demand webcast will outline the types of dementia and the current treatments available, along with the risk and benefits of pharmacological treatment.
Skilled Nursing Facilities Series: Urinary Tract Infections
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis on-demand webcast will explore the scope and impact of urinary tract infections (UTIs) in long-term care (LTC) settings, including prevalence, costs and clinical challenges. Participants will learn to differentiate UTIs from asymptomatic bacteriuria, apply evidence-based diagnostic criteria and implement strategies for prevention and treatment. Hydration practices, catheter maintenance and risk reduction to improve resident outcomes and reduce unnecessary antibiotic use will also be discussed.
Skilled Nursing Facilities Series: Diagnostic Stewardship
  • Disease management
  • Older adults
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
Activity descriptionThis activity will introduce the concept of diagnostic stewardship, emphasizing how appropriate test selection impacts patient care. Learners will explore the phases of diagnostic stewardship — pre-analytic, analytic and post-analytic — and learn the importance of pre-test probability in guiding test decisions. Real-world examples will illustrate common pitfalls and best practices in ordering diagnostic tests.
Updates in the Management of Macular Degeneration
  • Vision
  • 1.00 Attendance - General Attendance
  • 1.00 COPE - Optometrists
$0.00
This activity will provide an overview of the multiple subtypes of ARMD, including dry, intermediate, and wet ARMD, and geographic atrophy. It will explore existing and emerging therapies for ARMD subtypes, as well as their efficacy and safety profiles. In addition, testing strategies that can help determine the direction of ARMD management plans, as well as applications and programs for low-vision care, will be identified.
Heart Failure at the Crossroads: Early Recognition and Proactive Management
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Heart failure remains a leading cause of hospitalization and mortality. This session focuses on recognizing early signs, diagnostic tools, and evidence-based strategies to optimize care, improve patient quality of life, and reduce readmissions.
Facing Dementia: Early Diagnosis, Communication and Compassionate Care
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 ASWB - Social Workers
$0.00
Dementia care poses growing challenges in health care, requiring early recognition, accurate diagnosis, and compassionate, evidence-based care. This activity clarifies distinctions between dementia and mild cognitive impairment, reviews common subtypes, and highlights core strategies for improving care delivery and enhancing support for patients and caregivers.
COPD in 2025: Early Detection, Diagnostic Precision, and Emerging Therapies
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This session explores the latest updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) as outlined in the 2025 GOLD Report. Early case finding, refined spirometry protocols and novel therapeutic options are discussed, along with the importance of pre-bronchodilator spirometry, strategies for early detection in at-risk populations, and the integration of new treatments into updated treatment algorithms.

Pages